MustGrow Biologics Corp
XTSX:MGRO

Watchlist Manager
MustGrow Biologics Corp Logo
MustGrow Biologics Corp
XTSX:MGRO
Watchlist
Price: 0.57 CAD 9.62% Market Closed
Market Cap: CA$35.9m

Wall Street
Price Targets

MGRO Price Targets Summary
MustGrow Biologics Corp

There are no price targets for MGRO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
MustGrow Biologics Corp Competitors:
Price Targets
CDNA
CareDx Inc
33% Upside
CYBR
Cyberark Software Ltd
21% Upside
TCPC
BlackRock TCP Capital Corp
67% Upside
CASY
Caseys General Stores Inc
-2% Downside
PRQR
ProQR Therapeutics NV
440% Upside
TENB
Tenable Holdings Inc
49% Upside

Revenue
Forecast

214% / Year
Past Growth
697% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
214% / Year
Past Growth
697% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 3 years the compound annual growth rate for MustGrow Biologics Corp's revenue is 214%. The projected CAGR for the next 2 years is 697%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGRO's stock price target?
Not Available

MGRO doesn't have any price targets made by Wall Street professionals.

What is MustGrow Biologics Corp's Revenue forecast?
Projected CAGR
697%

For the last 3 years the compound annual growth rate for MustGrow Biologics Corp's revenue is 214%. The projected CAGR for the next 2 years is 697%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett